New approaches in metastatic melanoma: biological and molecular targeted therapies

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Classical metastatic melanoma treatments show limited efficacy.
• Significant advancements in understanding melanoma biology have been achieved.
• Key genetic lesions and intracellular signaling pathways are identified as therapeutic targets.

Purpose of the Study:

• To review novel therapeutic approaches for metastatic melanoma.
• To highlight the identification of intracellular and stromal targets.
• To discuss the role of small molecules, antibodies, and immunotherapy.

Main Methods:

• Review of current research on melanoma biology and targeted therapies.
• Identification of intracellular targets within tumor cells (membrane, cytoplasm, nucleus).
• Exploration of agents targeting stromal components like angiogenesis and the immune system.

Main Results:

• New therapeutic agents, including small molecules and antibodies, are under evaluation.
• Targeted therapies aim to inhibit melanoma proliferation, survival, migration, and invasion.
• Interference with angiogenesis and immune components represents another therapeutic strategy.

Conclusions:

• Advances in melanoma biology have led to promising new therapeutic targets.
• Small molecules offer a promising approach to selectively inhibit melanoma signaling pathways.
• Novel therapies targeting tumor cells and the tumor microenvironment are expanding treatment options.